Synthesis of N-quinonyltaurines

Amino Acids

Volumn 24, Issue 3, 2003, Pages 281-287

  Gorohovsky, S ^a   Temtsin Krayz, G ^a   Bittner, Shmuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Amino acids; Isocyanates; Isocyanurate; Quinones; Taurine

Indexed keywords

1,4 BENZOQUINONE; 1,4 NAPHTHOQUINONE; N QUINONYLTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ARTICLE; CHEMICAL BOND; CHEMICAL STRUCTURE; ELECTRON SPIN RESONANCE; MICHAEL ADDITION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SUBSTITUTION REACTION;

BENZOQUINONES; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NAPHTHOQUINONES; QUINONES; TAURINE;

EID: 0038408988     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-002-0407-4     Document Type: Article

References (33)

1. Alnabary M, Bittner S (2001) New quinone-amino acid conjugates linked via a vinylic spacer. Amino Acids: 20: 381-387
2. Anyanwu E, Harding GFA (1993) The involvement of taurine in the action mechanism of sodium valproate (VPA) in the treatment of epilepsy. Acta Physiol Pharmacol Ther Latinoam 43: 20-27
3. Azuma J, Sawamura A, Awata N (1992) Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 56: 95-99
4. Bade Shrestha-Dawadi P, Bittner S, Fridkin M, Rahimipour S (1996) On the synthesis of naphthoquinonyl heterocyclic amino acids. Synthesis: 1468-1472
5. Barbeau A, Inour N, Tsukada Y, Butterworth RF (1975) The neuropharmacology of taurine. Life Sci 17: 669-677
6. Bittner S, Gorohovsky S, Lozinsky E, Shames AI (2000a) EPR study of anion radicals of various N-quinonyl amino acids. Amino Acids 19: 439-449
7. Bittner S, Temtsin G, Sasson Y (2000b) Synthesis of N-quinonyl carbamates via 2-chloro-3-isocyanato-1,4-naphthoquinone. Synthesis: 1084-1086
8. Bittner S, Gorohovsky S, Paz-Tal (Levi) O, Becker JY (2002) Synthesis, electrochemical and spectral properties of some ω-N-quinonyl amino acids. Amino Acids 22: 71-93
9. Dimroth O, Kraft L, Aichinger K (1940) Action of thiophenols on quinone. Ann Chem 545: 124-139
10. Gaull GE, Rassin DK (1979) Taurine and brain development: human and animal correlates. In: Meisami E, Braziers MAB (eds) Developmental neurobiology. Raven Press New York, pp 461-477
11. Gaultier J, Hauw C (1969) Crystalline structure of 2- and 2,3-substituted 1,4-naphthoquinones. IX. 3-amino-1,4-naphthoqu-inones. Acta Cryst B25: 419
12. 2-induced alterations. Am J Pathol 125: 585-600
13. Gorohovsky S, Bittner S (2001) Novel N-quinonyl amino acids and their transformation to 3-substituted p-isoxazinones. Amino Acids 20: 135-144
14. Hajek M, Do KQ, Duc C, Boesiger P, Wieser HG (1997) Increased excitatory amino acid levels in brain cysts of epileptic patients. Epilepsy Res 28: 245-254
15. Hamamah S, Grizard G, Fignon A, Mortimer ST, Mortimer D (1999) In vitro therapy for sperm motility: specific and nonspecific treatments. Male Steril Motil Disord [Proc Int Symp], Meeting Date 1998. In: Hamamah S (ed) Springer, New York, pp 95-115
16. Hayes KC, Sturman JA (1981) Taurine in metabolism. Am Rev Nutr 1: 401-425
17. Hayes KC, Trautwein EA (1989) Taurine deficiency syndrome in cats. Small Anim Pract 19: 403-413
18. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72: 101-163
19. Imaki H, Sturman JA (1995) Taurine depletion and retinal degeneration resulting from dietary β-alanine in adult cats. Biomed Lett 51: 111-125
20. Invernizzi P, Setchell KDR, Crosignani A, Battezzati PR, Larghi A, O'Connell NC, Podda M (1999) Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology (Philadelphia) 29: 320-327
21. Kuriyama K (1980) Taurine as a neuromodulator. Fed Proc 39: 2680-2684
22. Masuda M, Horiksaka K, Koeda T (1986) Effect of taurine on neutrophil function in hyperlipidaemic rats. Jpn J Pharmacol 40: 478-480
23. McLoughlin DM, Stapleton PP, Bloomfield FJ (1991) Influence of taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response. Biochem Soc Trans 19: 73-78
24. Powis G (1989) Free radical formation by antitumor quinones. Free Rad Biol Med 6: 63-101
25. Rahimipour S, Weiner L, Fridkin M, Bade Shrestha-Dawadi P, Bittner S (1996) Novel naphthoquinonyl derivatives: potential structural components for the synthesis of cytotoxic peptides. Lett Peptide Sci 3: 263-274
26. Rahimipour S, Weiner L, Bade Shrestha-Dawadi P, Bittner S, Koh I, Fridkin M (1998) Cytotoxic peptides: naphthoquinonyl derivatives of luteinizing hormone-releasing hormone. Lett Peptide Sci 5: 421-427
27. Ryan JA (1989) Taurine deficiency in cats. Companion Anim Pract 19: 28-31
28. Scheller D, Szathmary S, Kolb J, Tegtmeier F (2000) Observations on the relationship between the extracellular changes of taurine and glutamate during cortical spreading depression, during ischemia, and within the area surrounding a thrombotic infarct. Amino Acids 19: 571-583
29. Shambaugh GE (1998) Malnutrition in late gestation. Pennington Cent Nutr Ser 8: 255-290
30. Silaeva TY, Dokshina GA, Yartsev EI, Yakovleva VV Arkhangel'skaya TE (1976) Effect of taurine on the carbohydrate metabolism of diabetic animals. Probl Endokrinol 22: 99-103
31. Sturman JA, Rassin DK, Gall DE (1977) Taurine in development. Life Sci 21: 1-22
32. Watson RGW, Redmond HP, Boucher-Hayes D (1994) Taurine upregulates antimicrobial function of human inflammatory cells. Surg Forum 45: 679-681
33. Wright CE, Tallan HH, Lin YY (1986) Taurine: biological update. Annu Rev Biochem 55: 427-453